- Home
- COEP vs SRZN Comparison
COEP vs SRZN Comparison
Compare COEP & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- SRZN
- Stock Information
- Founded
- COEP 2017
- SRZN 2015
- Country
- COEP United States
- SRZN United States
- Employees
- COEP N/A
- SRZN N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- COEP Health Care
- SRZN Health Care
- Exchange
- COEP Nasdaq
- SRZN Nasdaq
- Market Cap
- COEP 86.0M
- SRZN 97.3M
- IPO Year
- COEP N/A
- SRZN N/A
- Fundamental
- Price
- COEP $16.95
- SRZN $13.88
- Analyst Decision
- COEP
- SRZN Strong Buy
- Analyst Count
- COEP 0
- SRZN 2
- Target Price
- COEP N/A
- SRZN $38.50
- AVG Volume (30 Days)
- COEP 63.6K
- SRZN 23.0K
- Earning Date
- COEP 11-12-2025
- SRZN 11-05-2025
- Dividend Yield
- COEP N/A
- SRZN N/A
- EPS Growth
- COEP N/A
- SRZN N/A
- EPS
- COEP N/A
- SRZN N/A
- Revenue
- COEP $263,555.00
- SRZN $12,621,000.00
- Revenue This Year
- COEP N/A
- SRZN N/A
- Revenue Next Year
- COEP N/A
- SRZN N/A
- P/E Ratio
- COEP N/A
- SRZN N/A
- Revenue Growth
- COEP N/A
- SRZN N/A
- 52 Week Low
- COEP $2.31
- SRZN $5.90
- 52 Week High
- COEP $19.19
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- COEP 59.29
- SRZN 71.50
- Support Level
- COEP $16.00
- SRZN $13.28
- Resistance Level
- COEP $18.15
- SRZN $15.06
- Average True Range (ATR)
- COEP 1.60
- SRZN 0.73
- MACD
- COEP 0.06
- SRZN 0.15
- Stochastic Oscillator
- COEP 63.31
- SRZN 68.31
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).